Schizophrenia & Other Psychotic Disorders
Savvy Psychopharmacology
When to adjust the dosing of psychotropics in patients with renal impairment
Evidence-Based Reviews
Rediscovering clozapine: Adverse effects develop—what should you do now?
Benefit comes at the expense of monitoring for, and treating, an array of potential problems. Second of 3 parts.
Conference Coverage
Withdrawing risperidone spikes risk for psychotic relapse in hallucinating Alzheimer’s patients
Key clinical point: Risperidone-treated patients who reported severe hallucinations are likely to relapse if the drug is withdrawn. Major finding...
News
Statement warns of drugs causing or exacerbating heart failure
News
Childhood trauma, cannabis use disorders examined in schizophrenia
Video
Rediscovering clozapine
William J. Newman, MD, and Brianne M. Newman, MD, provide a glimpse of their 3-part series on the use of clozapine, which appears in the July,...
Savvy Psychopharmacology
Using lipid guidelines to manage metabolic syndrome for patients taking an antipsychotic
Evidence-Based Reviews
Rediscovering clozapine: After a turbulent history, current guidance on initiating and monitoring
FDA’s overhaul of management guidelines is good reason to get reacquainted. First of 3 parts.
Out Of The Pipeline
Long-acting injectable aripiprazole lauroxil for schizophrenia
Commentary
Scopolamine-induced mania: ‘Theoretically possible, but statistically improbable'
Commentary
Give serious thought before starting antipsychotics in elders
Delirium is one of the most difficult problems for hospitalists to manage, in part because our management of delirium is often learned on the fly...